Human antibody and memory B and T-cell responses after primary and booster immunisation against Neisseria meningitidis B

Vaccine

Volumn 29, Issue 43, 2011, Pages 7387-7394

  Cruz, Simone C ^a   Souza, Simone L ^a   Cruz, Aline C ^a   Silva, Giselle P ^a   Milagres, Lucimar G ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Memory B cell; Memory CD4 + T cells; Neisseria meningitidis; Vaccine

Indexed keywords

BACTERIUM ANTIBODY; CD4 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; MENINGITIS VACCINE; MENINGOCOCCUS VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; NEISSERIA MENINGITIDIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINE FAILURE;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; LECTINS, C-TYPE; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP B; RECEPTORS, CCR7; T-LYMPHOCYTES; VACCINATION;

EID: 80053444898     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.072     Document Type: Article

References (31)

1. Harrison L.H., Pelton S.I., Wilder-Smith A., Holst J., Safadi M.A., Vazquez J.A., et al. The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine 2011, 29:3363-3371.
2. Vogel U., Claus H. Vaccine development against Neisseria meningitidis. Microb Biotechnol 2011, 4:20-31.
3. Borrow R., Carlone G.M., Rosenstein N., Blake M., Feavers I., Martin D., et al. Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine 2006, 24:5093-5107.
4. van Alphen L., van den Dobbelsteen G. Meningococcal B vaccine development and evaluation of efficacy. Hum Vaccine 2008, 4:158-161.
5. Tangye S.G., Tarlinton D.M. Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009, 39:2065-2075.
6. Manz R.A., Thiel A., Radbruch A. A lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
7. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171:4969-4973.
8. Sallusto F., Lening D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
9. Harari A., Vallelian F., Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 2004, 34:3525-3533.
10. Hara T., Jung L.K., Bjorndahl J.M., Fu S.M. Human T cell activation. III. Rapid induction of a phosphorylated 28kD/32kD disulfidelinked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med 1988, 164:1988-2005.
11. Testi R., D'Ambrosio D., De Maria R., Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994, 15:479-483.
12. Ziegler S.F., Ramsdell F., Alderson M.R. The activation antigen CD69. Stem Cells 1994, 12:456-465.
13. Cruz S.C., Silva G.P., Sampaio F.J., Souza S.L., Dias A.A.S.O., Milagres L.G. Comparison of long-term humoral memory development after immunisation against Neisseria meningitis B or diphtheria toxoid. Vaccine 2010, 28:6841-6846.
14. Gioia C.A.C., Sousa A.B., Cruz S.C., Junior F.C.S., Andrade A.F.B., Sassi R.M., et al. Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunisation schedules. FEMS Immunol Med Microbiol 2005, 40:35-42.
15. Nanan R., Heinrich D., Frosch M., Kreth H.W. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory-B lymphocytes. Vaccine 2002, 20:498-504.
16. Lehmann A.K., Halstensen A., Holst J., Bassøe C.F. Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. J Immunol Methods 1997, 200:55-68.
17. Findlow J., Borrow R., Snape M.D., Dawson T., Holland A., John T.M., et al. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis 2010, 51(10):1127-1137.
18. Milagres L.G., Gorla M.C.A., Sacchi C.T., Rodrigues M.M. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect Immun 1998, 66:4755-4761.
19. Rouppe van der Voort E.M., Kuipers B., Brugghe H.F., van Unen L.M., Timmermans H.A., Hoogerhout P., et al. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines. FEMS Immunol Med Microbiol 1997, 17:139-148.
20. Delvig A.A., Michaelsen T.E., Aase A., Hoiby E.A., Rosenqvist E. Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils. Clin Immunol Immunopathol 1997, 84:27-35.
21. Lehmann A.K., Halstensen A., Aaberge I.S., Holst J., Michaelsen T.E., Sornes S., et al. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun 1999, 67:2552-2560.
22. McHeyzer-Williams L.J., McHeyzer-Williams M.G. Antigen-specific memory B cell development. Annu Rev Immunol 2005, 23:487-513.
23. Pollard A.J., Galassini R., van der Voort E.M., Hibberd M., Booy R., Langford P., et al. Cellular immune responses to Neisseria meningitidis in children. Infect Immun 1999, 67:2452-2463.
24. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007, 81:215-228.
25. Buisman A.M., de Rond C.G., Oztürk K., Ten Hulscher H.I., van Binnendijk R.S. Long-term presence of memory B-cells specific for different vaccine components. Vaccine 2009, 28:179-186.
26. Luijkx T.A., van Gaans-van den Brink J.A., van Dijken H.H., van den Dobbelsteen G.P., van Els C.A. Hyperproliferation of B cells specific for a weakly immunogenic PorA in a meningococcal vaccine model. Clin Vaccine Immunol 2008, 15:1598-1605.
27. Cruz S.C., Cruz A.C., Oliveira J.M., Soares A.M., Gioia C.A., Milagres L.G. Generation of long-lived plasma cells to serogroup B Neisseria meningitidis after murine immunisation with an outer membrane protein vaccine. Vaccine 2007, 25(27):5046-5052.
28. + T cells after recall immunization with tetanus toxoid. Clin Vaccine Immunol 2007, 14:1108-1116.
29. Wetzler L.M., Ho Y., Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 1996, 183:1151-1159.
30. Savi A., Kohler E., Toller I.M., Flavell R.A., Müller W., Roers A., et al. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 2011, 186:878-890.
31. Yamazaki S., Okada K., Maruyma A., Matsumoto M., Yagita H., Seya T. TLR2-dependent induction of IL-10 and Foxp3CD25CD4 regulatory T cells prevents effective anti-tumor immunity by Pam2 lipopeptides in vivo. PLoS ONE 2011, 6:e18833.